Unknown

Dataset Information

0

Isoliquiritigenin blunts osteoarthritis by inhibition of bone resorption and angiogenesis in subchondral bone.


ABSTRACT: Isoliquiritigenin (ISL), a natural flavonoid extracted from licorice, has been demonstrated to exert attenuation of osteoclastogenesis and anti-angiogenesis activity in a wide variety of cells. Here, we first evaluated the effects of ISL on pathogenesis of osteoarthritis in a mouse model of OA. The data showed that ISL blunted progression of OA and lowered the Osteoarthritis Research Society International (OARSI)-Modified Making Score and protected the articular cartilage. The thickness of calcified cartilage zone was significantly decreased in ISL-treated ACLT mice compared with vehicle group. ISL increased expression level of lubricin and decreased collagen X (Col X), matrix metalloproteinase-13 (MMP-13). Moreover, ISL reduced aberrant active subchondral bone remodelling, including lowered trabecular pattern factor (Tb.pf) and increased bone volume/tissue volume (BV/TV, %) and thickness of subchondral bone plate (SBP) compared with vehicle-treated group. The results of immunostaining further revealed that ISL directly reduced RANKL-RANK-TRAF6 singling pathway induced osteoclastogenesis, prevented abnormal bone formation through indirect inhibition of TGF-? release. Additionally, ISL exerts anti-angiogenesis effects in subchondral bone through direct suppression of MMP-2. These results indicated that ISL attenuates progression of OA by inhibition of bone resorption and angiogenesis in subchondral bone, indicating that this may be a potential preventive therapy for OA.

SUBMITTER: Ji B 

PROVIDER: S-EPMC5788865 | biostudies-other | 2018 Jan

REPOSITORIES: biostudies-other

altmetric image

Publications

Isoliquiritigenin blunts osteoarthritis by inhibition of bone resorption and angiogenesis in subchondral bone.

Ji Baochao B   Zhang Zhendong Z   Guo Wentao W   Ma Hairong H   Xu Boyong B   Mu Wenbo W   Amat Abdusami A   Cao Li L  

Scientific reports 20180129 1


Isoliquiritigenin (ISL), a natural flavonoid extracted from licorice, has been demonstrated to exert attenuation of osteoclastogenesis and anti-angiogenesis activity in a wide variety of cells. Here, we first evaluated the effects of ISL on pathogenesis of osteoarthritis in a mouse model of OA. The data showed that ISL blunted progression of OA and lowered the Osteoarthritis Research Society International (OARSI)-Modified Making Score and protected the articular cartilage. The thickness of calci  ...[more]

Similar Datasets

| S-EPMC9454853 | biostudies-literature
| S-EPMC7205438 | biostudies-literature
| S-EPMC6587439 | biostudies-literature
| S-EPMC9333271 | biostudies-literature
| S-EPMC9670483 | biostudies-literature
| S-EPMC3676689 | biostudies-literature
| S-EPMC6804921 | biostudies-literature
| S-EPMC5358796 | biostudies-literature
| S-EPMC7859330 | biostudies-literature
| S-EPMC6320646 | biostudies-literature